id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-5337	Hill, Rachel C; Wang, Yu; Shaikh, Bilal; Ong, Michael M.; Christos, Paul J.; Lipner, Shari R.	Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss	2025	4	.pdf	application/pdf	1895	93	69	Not Hispanic/Latin/SpanishOrigin 118 (85%) 115 (85%) 3 (100%) Max Daily Dose, mg 0.2 Median (Q1,Q3) 100 (50,100) 100 (50,100) 100 (100,200) Mean (SD) 99 (51) 98 (50) 135 (60) Range 25,200 25,200 75,200 Max Daily Dose Group, mg n(%) 0.2 ≤50 60 (32%) 60 (33%) 0(0%) 75-100 35 (19%) 33 (18%) 2 (40%) 125-200 90 (49%) 87 (48%) 3 (60%) 1Wilcoxon rank sum test; Fisher’s exact test; Pearson’s chi-squared test. We showed that spironolactone-treated alopecia patients did not have significant BP changes, even at doses ≥100 mg, consistent with Desai et.	cache/dpc-5337.pdf	txt/dpc-5337.txt